Use of immunohistochemical evaluation of DNA repair proteins to demonstrate cisplatin response prediction in resected NSCLC squamous cell carcinoma.
W. E. Pierceall
Stock Ownership - On-Q-ity
Research Funding - On-Q-ity
K. M. Sprott
Stock Ownership - On-Q-ity
Research Funding - On-Q-ity
E. Brambilla
No relevant relationships to disclose
R. Pirker
No relevant relationships to disclose
H. H. Popper
No relevant relationships to disclose
X. Wang
Stock Ownership - On-Q-ity
Research Funding - On-Q-ity
Y. Chen
Stock Ownership - On-Q-ity
Research Funding - On-Q-ity
S. Quan
Stock Ownership - On-Q-ity
Research Funding - On-Q-ity
M. Filipits
No relevant relationships to disclose
L. Alaparthi
Stock Ownership - On-Q-ity
Research Funding - On-Q-ity
J. Kutok
Consultant or Advisory Role - On-Q-ity
Stock Ownership - On-Q-ity
D. T. Weaver
Consultant or Advisory Role - On-Q-ity
Stock Ownership - On-Q-ity
Research Funding - On-Q-ity
M. Al-Adhami
Research Funding - On-Q-ity
F. Andre
No relevant relationships to disclose
T. Le Chevalier
No relevant relationships to disclose
B. E. Ward
Stock Ownership - On-Q-ity
Research Funding - On-Q-ity
J. Soria
No relevant relationships to disclose